Adaptyv Biosystems secures funding from Y Combinator

Adaptyv Biosystems secures funding from Y Combinator

5.8.2021- Adaptyv Biosystems – an EPFL-based startup which specialises in antibody screening – has received a pre-seed investment from the world’s most selective startup accelerator, Y Combinator. Based in Mountain View, California, Y Combinator has funded over 3,000 companies including Airbnb, Coinbase and Ginkgo Bioworks

read more in EPFL Innovation News